Biomea Fusion, Inc.BMEANASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank20
3Y CAGR-71.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-71.6%/yr
Annual compound
Percentile
P20
Within normal range
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 15.15% |
| 2023 | 63.52% |
| 2022 | 124.01% |
| 2021 | 662.63% |
| 2020 | 236.17% |
| 2019 | 0.00% |